Advertisement
EMBC vs EMITF
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EMBC is a Hold and EMITF is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
EMBC’s FA Score shows that 2 FA rating(s) are green whileEMITF’s FA Score has 1 green FA rating(s).
- EMBC’s FA Score: 2 green, 3 red.
- EMITF’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
EMBC’s TA Score shows that 6 TA indicator(s) are bullish while EMITF’s TA Score has 3 bullish TA indicator(s).
- EMBC’s TA Score: 6 bullish, 4 bearish.
- EMITF’s TA Score: 3 bullish, 5 bearish.
Price Growth
EMBC (@Pharmaceuticals: Other) experienced а +11.48% price change this week, while EMITF (@Financial Conglomerates) price change was -2.70% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.19%. For the same industry, the average monthly price growth was -0.65%, and the average quarterly price growth was +3.82%.
The average weekly price growth across all stocks in the @Financial Conglomerates industry was +4.96%. For the same industry, the average monthly price growth was +4.87%, and the average quarterly price growth was +58.33%.
Reported Earning Dates
EMBC is expected to report earnings on Dec 23, 2025.
Industries' Descriptions
@Pharmaceuticals: Other (+0.19% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Financial Conglomerates (+4.96% weekly)Financial conglomerates usually encompass a wide range of financial services including (not necessarily limited to) investment banking, insurance, capital raising/underwriting, trading of financial securities, investment advisory services, wealth management of high net-worth individuals, and retail banking. Think Citigroup, American Express Company, ING Group.
| EMBC | EMITF | EMBC / EMITF | |
| Capitalization | 801M | 20.6M | 3,888% |
| EBITDA | 207M | N/A | - |
| Gain YTD | -32.049 | 20.000 | -160% |
| P/E Ratio | 9.64 | N/A | - |
| Revenue | 1.08B | N/A | - |
| Total Cash | 209M | N/A | - |
| Total Debt | 1.55B | N/A | - |
EMITF | ||
|---|---|---|
OUTLOOK RATING 1..100 | 95 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 16 Undervalued | |
PROFIT vs RISK RATING 1..100 | 60 | |
SMR RATING 1..100 | 91 | |
PRICE GROWTH RATING 1..100 | 56 | |
P/E GROWTH RATING 1..100 | 100 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| EMBC | EMITF | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 87% | 3 days ago 63% |
| Stochastic ODDS (%) | 3 days ago 89% | 3 days ago 44% |
| Momentum ODDS (%) | 3 days ago 73% | 3 days ago 52% |
| MACD ODDS (%) | 3 days ago 83% | 3 days ago 51% |
| TrendWeek ODDS (%) | 3 days ago 74% | 3 days ago 51% |
| TrendMonth ODDS (%) | 3 days ago 75% | 3 days ago 46% |
| Advances ODDS (%) | 5 days ago 76% | N/A |
| Declines ODDS (%) | 3 days ago 85% | N/A |
| BollingerBands ODDS (%) | 3 days ago 79% | 3 days ago 64% |
| Aroon ODDS (%) | 3 days ago 81% | 3 days ago 53% |
Advertisement
EMBC and
Correlation & Price change
A.I.dvisor indicates that over the last year, EMBC has been loosely correlated with NEOG. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if EMBC jumps, then NEOG could also see price increases.
| Ticker / NAME | Correlation To EMBC | 1D Price Change % | ||
|---|---|---|---|---|
| EMBC | 100% | -1.30% | ||
| NEOG - EMBC | 37% Loosely correlated | -1.27% | ||
| WAT - EMBC | 37% Loosely correlated | -0.67% | ||
| RVTY - EMBC | 36% Loosely correlated | +1.49% | ||
| MTD - EMBC | 36% Loosely correlated | -0.10% | ||
| BIO - EMBC | 35% Loosely correlated | -0.54% | ||
More | ||||
EMITF and
Correlation & Price change
A.I.dvisor indicates that over the last year, EMITF has been loosely correlated with STSS. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if EMITF jumps, then STSS could also see price increases.
| Ticker / NAME | Correlation To EMITF | 1D Price Change % | ||
|---|---|---|---|---|
| EMITF | 100% | N/A | ||
| STSS - EMITF | 38% Loosely correlated | -2.93% | ||
| AVHHL - EMITF | 26% Poorly correlated | N/A | ||
| GCTK - EMITF | 22% Poorly correlated | +0.87% | ||
| NUWE - EMITF | 22% Poorly correlated | -1.77% | ||
| EMBC - EMITF | 21% Poorly correlated | -1.30% | ||
More | ||||